XunZi, an AI biologist, reveals disease-modifying targets.
In Parkinson's disease (PD), where complex mechanisms and limited targets hamper therapy development, XunZi identifies aberrant activation of CHK2 and IRAK4 kinases across multiple models and establishes a paradigm-shifting framework to translate fragmented biomedical knowledge and data into actionable therapeutics.